# SMPD2

## Overview
SMPD2 is a gene that encodes the enzyme neutral sphingomyelinase 1 (nSMase1), which is integral to sphingolipid metabolism. This enzyme is categorized as a transmembrane protein and is primarily located in the endoplasmic reticulum and nuclear matrix. nSMase1 is responsible for the hydrolysis of sphingomyelin into ceramide and phosphocholine, processes that are vital for cellular functions such as apoptosis, cell growth, and differentiation (Choezom2022Neutral; Yi2023Molecular). The enzyme's activity is modulated by divalent cations and is involved in various signaling pathways, including PI3K/Akt and Wnt, which influence cell cycle progression and cellular stress responses (Choezom2022Neutral; Choezom2024Investigating). Due to its role in sphingolipid metabolism, SMPD2 is implicated in several diseases, including neurodegenerative disorders and cancer, making it a potential target for therapeutic interventions (Xiang2021Physiological; Clarke2006The).

## Structure
The SMPD2 gene encodes the enzyme human neutral sphingomyelinase 1 (hSMPD2), which plays a crucial role in sphingolipid metabolism. The molecular structure of hSMPD2 has been determined using cryo-electron microscopy, revealing a resolution of 3.07 Å (Yi2023Molecular). The protein adopts a dimeric architecture, consisting of four transmembrane helices (TMHs) that integrate into the membrane, forming a dimeric hydrophobic cleft that stabilizes the protein through interactions with lipids (Yi2023Molecular). The dimer interface is primarily formed by TMH2 within the transmembrane domain (TMD) and β6 and α3 within the catalytic domain (CAD), stabilized by hydrophobic and π-π interactions (Yi2023Molecular).

The catalytic mechanism of hSMPD2 involves a single-metal-mediated process, with a magnesium ion coordinated by conserved residues N15 and E49, essential for sphingomyelin hydrolysis (Yi2023Molecular). The D111-K116 loop domain, also known as the 'DK switch,' is crucial for substrate hydrolysis, forming a salt-bridge interaction that regulates substrate access (Yi2023Molecular). The enzyme's structure includes a substrate-binding pocket with an exposed groove, ready for substrate interaction (Yi2023Molecular). The protein is primarily located in the endoplasmic reticulum and nuclear matrix, and its activity can be modulated by phosphorylation (Yi2023Molecular).

## Function
SMPD2 encodes the enzyme neutral sphingomyelinase 1 (nSMase1), which plays a crucial role in the hydrolysis of sphingomyelin to produce ceramide and phosphocholine. This enzymatic activity is essential for various cellular processes, including apoptosis, cell growth, and differentiation. nSMase1 is primarily located in the endoplasmic reticulum (ER) and nuclear matrix, where it contributes to maintaining cellular homeostasis and ER function (Choezom2022Neutral; Yi2023Molecular).

In healthy human cells, nSMase1 is involved in the unfolded protein response (UPR), a critical process activated during ER stress to restore protein folding and maintain ER functions. SMPD2 knockdown impairs the UPR, indicating the enzyme's importance in cellular adaptation to stress (Choezom2024Investigating). nSMase1 also influences cell cycle progression, as its knockdown leads to G1 phase arrest and affects pathways such as PI3K/Akt and Wnt signaling (Choezom2022Neutral).

The enzyme's activity is regulated by divalent cations and is influenced by JNK signaling, which stimulates ceramide generation and apoptosis (Yi2023Molecular). nSMase1's role in sphingomyelin hydrolysis and ceramide generation is cell-type and pathway-specific, highlighting its nuanced function in lipid metabolism and cellular physiology (Yi2023Molecular).

## Clinical Significance
The SMPD2 gene, encoding neutral sphingomyelinase 2 (nSMase2), plays a significant role in various diseases due to its involvement in sphingolipid metabolism. Alterations in SMPD2 expression or activity have been linked to neurodegenerative diseases such as Alzheimer's disease. In Alzheimer's, nSMase2 is implicated in the cytotoxic action of amyloid-β peptide, and its inhibition can reduce amyloid plaque generation and improve cognitive function in models of the disease (Xiang2021Physiological; Clarke2006The).

In cancer, particularly hepatocellular carcinoma, overexpression of nSMase2 has been shown to reduce cell proliferation, suggesting a potential tumor-suppressive role. Conversely, nSMase2 knockout mice exhibit increased liver cancer incidence, highlighting its importance in tumor suppression (Xiang2021Physiological).

SMPD2 expression changes are also associated with diabetic kidney disease, where lower expression levels correlate with decreased ceramide synthesis. Inducing SMPD2 expression in renal cells can increase ceramide levels and promote autophagy, suggesting a protective role against kidney damage (Yi2023Molecular).

These findings indicate that SMPD2 is a critical factor in the pathophysiology of several conditions, making it a potential target for therapeutic interventions.

## Interactions
SMPD2, also known as neutral sphingomyelinase 1 (nSMase1), participates in various protein interactions that influence cellular processes. It interacts with the PI3K/Akt signaling pathway, where it negatively affects the G1-S transition by reducing phosphorylated Akt levels, impacting cell cycle progression (Choezom2022Neutral). SMPD2 also interacts with the Wnt signaling pathway by downregulating β-catenin and Wnt3a protein levels, which affects cell proliferation (Choezom2022Neutral).

In the context of the endoplasmic reticulum (ER), SMPD2 interacts with several ER membrane proteins, including SRPRB and SSR2, which are crucial for mRNA targeting to the ER (Choezom2022Neutral). It also interacts with GPI anchor attaching proteins, indicating a role in ER function and protein translation (Choezom2022Neutral). SMPD2's interaction with SCAP, a protein associated with sterol regulation, suggests its involvement in lipid homeostasis (Choezom2024Investigating).

These interactions highlight SMPD2's role in regulating ER functions and cellular fitness, particularly during ER stress and cell cycle regulation. Its activity is essential for maintaining cellular homeostasis and influencing various signaling pathways (Choezom2022Neutral).


## References


1. (Choezom2022Neutral) Neutral sphingomyelinase 1 regulates cellular fitness at the level of ER stress and cell cycle. This article has 2 citations.

[2. (Xiang2021Physiological) Hongjiao Xiang, Shengjie Jin, Fenglang Tan, Yifan Xu, Yifei Lu, and Tao Wu. Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase. Biomedicine &amp; Pharmacotherapy, 139:111610, July 2021. URL: http://dx.doi.org/10.1016/j.biopha.2021.111610, doi:10.1016/j.biopha.2021.111610. This article has 39 citations.](https://doi.org/10.1016/j.biopha.2021.111610)

3. (Choezom2024Investigating) Investigating the role of neutral sphingomyelinases in membrane vesicle trafficking. This article has 0 citations.

[4. (Yi2023Molecular) Jingbo Yi, Boya Qi, Jian Yin, Ruochong Li, Xudong Chen, Junhan Hu, Guohui Li, Sensen Zhang, Yuebin Zhang, and Maojun Yang. Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hsmpd2). Nature Communications, November 2023. URL: http://dx.doi.org/10.1038/s41467-023-43580-w, doi:10.1038/s41467-023-43580-w. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-43580-w)

[5. (Clarke2006The) Christopher J. Clarke, Christopher F. Snook, Motohiro Tani, Nabil Matmati, Norma Marchesini, and Yusuf A. Hannun. The extended family of neutral sphingomyelinases. Biochemistry, 45(38):11247–11256, August 2006. URL: http://dx.doi.org/10.1021/bi061307z, doi:10.1021/bi061307z. This article has 137 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi061307z)